Vol. 2 No. 4 (2015): October-December 2015

Original Research Articles

• An interdisciplinary analysis of genetically modified vaccines: from clinical trials to market

  Bahar Ramezanpour, Tommy Riemens, Linda van de Burgwal, E. Claassen

  64-74

  DOI: 10.18203/2349-3259.ijct20151235

  • PDF

• Funding of clinical trials in Brazil for the development of new drugs: who are the sponsors?

  Ricardo Eccard da Silva, Angélica Amorim Amato, Maria Rita Carvalho Garbi Novaes

  75-84

  DOI: 10.18203/2349-3259.ijct20151236

  • PDF

• Comparison of bone mineral density and serum minerals in pre and post-menopausal women

  Sasmita Mishra, M. Manju, B. D. Toora, S. Mohan, B. P. Venkatesh

  85-90

  DOI: 10.18203/2349-3259.ijct20151237

  • PDF

• Cardiovascular disease risk assessment in diabetes and metabolic syndrome patients with and without non-alcoholic fatty liver disease

  Mohammed Alim, Rakesh K. Sahay, Nuwairah Hafiz, B. Prabhakar, Mohammed Ibrahim

  91-96

  DOI: 10.18203/2349-3259.ijct20151238

  • PDF

• The effect of rectal progesterone on latency period as well as maternal and prenatal outcome between 24 to 33 weeks

  Fadwah Tahir, Mohammed Badawi, Abdulelah Nuqali, Yasir Katib, Irfanallah Muhammad Siddiqui, Fawaz Edris, Entsar Madani, Muaid Morad, Omar Taibah, Yahyah Al-Ghamdi

  97-101

  DOI: 10.18203/2349-3259.ijct20151239

  • PDF

• Design and protocols of the GIRAF prevention trial: A randomized, prospective, parallel, two-center study to compare cognitive outcomes in subjects with atrial fibrillation using warfarin or dabigatran

  André A. S. F. de Toledo, Pai C. Yu, Danielle M. Guallandro, Daniela Calderaro, Gabriel A. L. do Carmo, Breno F. S. Fernandes, Marina A. Neves, Raul Feitosa, Ana Carolina Rodrigues, Antônio Luiz P. Ribeiro, Ricardo Nitrini, Paulo Caramelli, Bruno Caramelli

  102-107

  DOI: 10.18203/2349-3259.ijct20151240

  • PDF